// App-Quantinova.ai

: Quality of Life in Patients with Chronic Lymphocytic Leukemia Initiating Venetoclax in Routine Clinical Practice across Canada: Results from the Devote Study

Researchers

Presenter

  • Andrew Aw

Principal Investigators

  • Versha Banerji

  • Sarah-Jane Bull

  • Pierre-André Fournier

  • Anthea Peters

  • Carolyn Owen

Medical Centers

  • The Ottawa Hospital, Ottawa, Canada

  • CancerCare Manitoba Research Institute, CancerCare Manitoba, Winnipeg, Canada

  • Tom Baker Cancer Centre, University of Calgary and Alberta Health Services, Calgary, Canada

  • Department of Oncology, University of Alberta, Edmonton, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Endocrine/metabolic Diseases (ME)

  • Gastroenterology (GU)

  • Central Nervous System (CNS)

  • Oncology (ONC)

Disease

  • Chronic Lymphocytic Leukemia

  • Constipation

  • Insomnia

  • Lymphomas

  • Dyspnea

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Venetoclax

  • Ibrutinib

  • Rituximab

Outcome

  • N/A

Study Design

  • Open Label

  • Observational

  • Single Arm

  • Multicenteric

  • Global

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved